Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 6,733 All time
- Disclosed funding
- $804.6B 4913 disclosed amounts
- Median round
- $12.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VT Develops intelligent, logic-gated therapeutics for solid tumors | $61M | Series A | Biotech | China | Investors | |
| P Develops AI-enabled cardiac diagnostics platform for ECG interpretation | Undisclosed | Seed | Healthtech | United Kingdom | Investors | |
Terra IndustriesCompany profile Autonomous security hardware and software for governments and critical infrastructure operators. Autonomous security hardware and software for governments and critical infrastructure operators. | $11.8M | Undisclosed | Defense tech | Nigeria | Investors | |
| T Provides spa, bathhouse, leisure, and activity management software | $30M | Series A | Enterprise software | United Kingdom | Investors | |
| N Develops implant for treating articular cartilage defects in the knee | $4.1M | Seed2Seed | Biotech | United States | Investors | |
| AP Develops, constructs, owns, and operates renewable energy assets | $200M | StrategicUndisclosed | Climate tech | United States | Investors | |
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors | |
Zepo IntelligenceCompany profile Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. | $15M | Seed | Cybersecurity | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
AI4EyesCompany profile AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. | CA$3.7M | Undisclosed | AI | Canada | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Unsiloed AI, Model ML, Science Corporation
178rounds5led - 2Andreessen Horowitz (a16z)
Isomorphic Labs, Larridin, Northwood Space
147rounds36led - 3General Catalyst
Rox, Mercor, Clara
142rounds26led - 4NVIDIA
Noeri, Agile Robots, Mercor
103rounds2led - 5Lightspeed
Payhawk, Nominal, Hypersonica
101rounds16led
Latest digests
Archive →Weekly funding picks, November 9–15, 2026
Lucid’s credit commitment, Mercor’s employee tender, factory and clinical robotics, Cocos’s first external capital and Gama’s satellite-power production line.
Browse rounds by topic
Geography
Featured selections
Nahato adds ¥4bn in bank debt for regional and esports expansion
Nahato’s new ¥4bn borrowing brings cumulative financing to ¥10bn. The company plans a Kansai office, recruitment, regional services and gaming expansion.
Read the research →